Regulatory Dashboard | GMO Regulatory Considerations for Advanced Therapies in Europe

In the European Union (EU), gene therapy medicinal products (GTMP) are a subset of advanced therapy medicinal products (ATMPs) and may consist of or contain genetically modified organisms (GMOs). The EU GMO frameworks were developed to address environmental concerns related to GMOs for agricultural use.